Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of KC706 in rheumatoid arthritis patients on stable methotrexate
2006-002645-37Phase 2Completed
- Sponsor
- Kemia
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing KC706 + methotrexate with Placebo + methotrexate (2 arms). Primary endpoint: Reduction in C-reactive protein (CRP). Started Jun 2006; status: completed.
02
Drugs
KC706
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2006-002645-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002645-37.